A Cambridge MA-based company, PanTher Therapeutics, raised $5.4M in Series A funding. The round was led by Catalyst Health Ventures, with participation from Angel Physicians Fund and Craig Bloem (Founder, Inoviant). 

Co-Founded by SLP Fellow, Laura Indolfi, PanTher is an oncology company advancing new treatments for solid tumors through direct delivery of proven therapeutic agents. The company’s proprietary platform is based on a technology developed at MIT and was subsequently in-licensed by PanTher.

PanTher Therapeutics deals with some of the biggest challenges in treating cancer with the help of engineering principles. By unlocking a drug’s full potential, the company’s adaptable platform enables oncologists to treat deadly cancers with enhanced therapeutic response and minimal side effects.

Read More: https://bit.ly/3qXBIdK 
Website: https://www.panthertx.com/